Overdiagnosis Explainer
Overdiagnosis happens when a test correctly finds a disease or abnormality that would never have caused symptoms, disability, or death during a person’s lifetime. The finding is real, not a false positive. The problem is that medicine often cannot tell with certainty which detected cases will progress and which will remain harmless.
Screening can increase overdiagnosis because it looks for disease before symptoms appear. Some cancers, small nodules, and other changes grow so slowly that a person would never have known about them without testing. Detecting these conditions can make survival statistics look better even when the screening program does not reduce deaths.
Overdiagnosis can lead to additional imaging, biopsies, surgery, radiation, medicines, cost, and anxiety. Those downstream effects are sometimes called overtreatment. At the same time, screening can save lives when it identifies dangerous disease early enough for effective treatment. The balance differs by condition, age, risk, and test.
Good screening decisions use evidence about both benefits and harms. Clinicians and patients may consider a person’s risk factors, life expectancy, values, and what would happen after an abnormal result. Overdiagnosis is not a reason to reject all screening; it is a reason to choose screening thoughtfully and interpret results in context.
A false positive suggests disease that later testing shows is not present. Overdiagnosis identifies a genuine abnormality, but one that would not have harmed the person.
Both can trigger follow-up procedures, but their causes and implications are different. A confirmed diagnosis can still represent overdiagnosis.
For an individual patient, doctors usually cannot know what an untreated screen-detected condition would have done over many years. Researchers estimate overdiagnosis by comparing groups over time.
Earlier detection can also lengthen the measured time from diagnosis to death without changing the date of death, a statistical effect called lead-time bias.
Ask how likely the test is to prevent serious illness or death for someone with your risk profile, and how often it leads to further testing or treatment.
Also ask what choices follow an abnormal result, including whether active surveillance is appropriate. Decisions should reflect current guidance and individual circumstances.
Explore more "Explainers"
Discover additional explainers across politics, science, business, technology, and other fields. Each explainer breaks down a complex idea into clear, everyday language—helping you better understand how major concepts, systems, and debates shape the world around us.
